Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Penta Valent Tbk
PEVE
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
35
ROE
16,49%
ROA
4,30%
Book Value
214
Net Income
31,09 M
Total Sales
1,84 T
Total Assets
1,44 T
DER
2.83x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
10,72%
TANCORP MEGA BUANA PT 🔗
80,00%
Corporate · Lokal
PT. MULIA PRIMA TUNGGAL 🔗
4,93%
Firm · Lokal
FRANXISCUS AFAT ADINATA NURSALIM 🔗
1,60%
Individual · Lokal
REKSA DANA SAM INDONESIA EQUITY FUND 🔗
1,40%
Mutual Funds · Lokal
PT BEMEROCA UNITI ABADI HARMONI 🔗
1,35%
Corporate · Lokal
Tentang Perusahaan
PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Produk & Lini Bisnis
The Company is primarily engaged in distribution pharmaceutical products, medical equipment and consumer products.
Dewan Direksi
S
Sukismo
President Director
FA
Franxiscus Afat Adinata Nursalim
Director
MP
Melisa Patricia
Director
Dewan Komisaris
HT
Hermanto Tanoko
President Commissioner
LR
Lukas Rusli
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
 %
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
3,5M 2,7M 1,8M 887jt 0 Sales 2025Q2: Rp 1.685.734.666 Net Income 2025Q2: Rp 28.973.091 2025Q2 Sales 2025Q3: Rp 2.587.588.168 Net Income 2025Q3: Rp 44.206.970 2025Q3 Sales 2025Q4: Rp 3.547.994.058 Net Income 2025Q4: Rp 55.326.814 2025Q4 Sales 2026Q1: Rp 871.412.724 Net Income 2026Q1: Rp 15.919.008 2026Q1 Sales 2026Q2: Rp 1.836.715.300 Net Income 2026Q2: Rp 31.086.248 2026Q2
2025 Q2
EPS 33
ROE 18,34%
2025 Q3
EPS 33
ROE 17,80%
2025 Q4
EPS 31
ROE 15,99%
2026 Q1
EPS 36
ROE 17,60%
2026 Q2
EPS 35
ROE 16,49%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 1,84 T 31,09 M 1,44 T 377,06 M 35 16,49% 2.83x
2026 Q1 871,41 M 15,92 M 1,37 T 361,89 M 36 17,60% 2.78x
2025 Q4 3,55 T 55,33 M 1,39 T 345,97 M 31 15,99% 3.02x
2025 Q3 2,59 T 44,21 M 1,32 T 331,20 M 33 17,80% 2.97x
2025 Q2 1,69 T 28,97 M 1,32 T 315,97 M 33 18,34% 3.17x
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 312 214 4,30%
2026 1 496 205 4,65%
2025 4 550 196 3,98%
2025 3 510 188 4,48%
2025 2 328 179 4,40%
Data diperbarui pada: 2026-05-12 11:34:09